Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension

Journal of Human Hypertension

Volumn 21, Issue 10, 2007, Pages 802-807

  Leoncini, G ^a   Ratto, E ^a   Viazzi, F ^a   Vaccaro, V ^a   Parodi, A ^a   Falqui, V ^a   Conti, N ^a   Tomolillo, C ^a   Deferrari, G ^a   Pontremoli, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

ALBUMINURIA; ARTERIES; BLOOD PRESSURE MONITORING, AMBULATORY; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; ELASTICITY; FEMALE; HUMANS; HYPERTENSION; ITALY; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; URIC ACID;

EID: 34548848543     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002240     Document Type: Article

References (34)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
2. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32: 454-460.
3. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003; 63: 1852-1860.
4. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-4241.
5. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its, relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002; 106: 2085-2090.
6. Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T et al. Ambulatory arterial stiffness index derived from 24-h ambulatory blood pressure monitoring. Hypertension 2006; 47: 359-364.
7. Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V et al. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 2006; 48: 397-402.
8. Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S et al. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006; 47 365-370.
9. Schillaci G, Pirro, M, Vaudo G, Marmarino MR, Savarese G, Pucci G et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 2005; 45: 1078-1082.
10. Nakanishi N, Suzuki K, Tatara K. Clustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanese men. Angiology 2003; 54: 551-559.
11. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study. Hypertension 1997; 30 1135-1143.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
14. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
15. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
16. Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon H et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 2006; 186: 345-353.
17. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004; 43 1388-1395.
18. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cordiol 2006; 47: 72-75.
19. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997; 350(Suppl 1): S9-S13.
20. DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: A complex metabolic web. J Cardiovasc Pharmacol 1992; 20(Suppl 11): S1-S16.
21. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994; 93: 2365-2371.
22. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study. Circulation 2002; 106: 2659-2665.
23. Kahn R, Buse J, Ferrannini E, Stem M. American diabetes association; European association for the study of diabetes. The metabolic syndrome: time for a critical appraisal: Joint statement from the American diabetes association and the European association for the study of diabetes. Diabetes Care 2005; 28: 2289-2304.
24. Reaven GM. The metabolic syndrome: Is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237-1247.
25. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
26. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
27. Ishizaka N, Ishizaka Y, Toda, EI, Hashimoto H, Nagai R, Yamakado M. Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 2007; 192: 131-137.
28. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong YY et al. Relationships of C-reactive protein, uric acid, and glomerular filtration rate to arterial stiffness in Japanese subjects. J Hum Hypertens 2005; 19: 907-913.
29. Rathmann W, Funkhouser E, Dyer AR, Roseman JM. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998; 8 250-261.
30. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25 1038-1044.
31. Laurent S. Surrogate measures of arterial stiffness: Do they have additive predictive value or are they only surrogates of a surrogate? Hypertension 2006; 47: 325-326.
32. Gavish B. Correlating ambulatory blood pressure measurements with arterial stiffness: A conceptual inconsistency? Hypertension 2006; 48: E108.
33. Ratto E, Leoncini G, Viazzi F, Vaccaro V, Falqui V, Parodi A et al. Ambulatory arterial stiffness index and renal abnormalities in primary hypertension. J Hypertens 2006; 24: 2033-2038.
34. Hansen TW, Staessen JA, Torp-Pedersen C, Rasmussen S, Li Y, Dolap E et al. Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens 2006; 24: 2247-2253.